Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Congress 2022

Programme Registration Abstracts Industry Participation Venue & Accommodation Press & Media Social Media Contacts

Start date: 14 Oct 2022
End date: 16 Oct 2022
Location: Amsterdam, Netherlands

MAP is the leading global meeting dedicated to precision oncology, defined as molecular profiling of tumours to identify targetable alterations. This oncology field is fast evolving and has now entered the mainstream of clinical practice.

At MAP 2022, international key opinion leaders will explain how to use genomic data for treating cancer patients, matching such data to a specific drug or therapy, based on the genetic drivers detected in the patients’ tumours, and they will debate about the future challenges in precision oncology.

The innovative, LIVE Plus, Congress format will offer participants the option to attend in person, in Amsterdam, or online, through a virtual platform, from 14 to 16 October 2022.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.